Regentis Biomaterials (RGNT) Assets (2024 - 2025)

Regentis Biomaterials (RGNT) reported Assets of $7.6 million for Q4 2025, up 1480.5% year-over-year from $482000.0 in Q4 2024, and up 1480.5% quarter-over-quarter from $482000.0 in Q4 2024.

Regentis Biomaterials (RGNT) Assets (2024 - 2025) Analysis & Trends

Regentis Biomaterials (RGNT) has 2 years of Assets data on file, last reported at $7.6 million in Q4 2025.

  • Assets for Q4 2025 came in at $7.6 million, up 1480.5% year-over-year; the trailing twelve-month figure through Dec 2025 was $7.6 million (up 1480.5% YoY), and the FY2025 annual result was $7.6 million, up 1480.5% from the prior year.
  • Assets improved to $7.6 million in Q4 2025 per RGNT's latest filing, from $482000.0 in the prior quarter.
  • Over five years, Assets peaked at $7.6 million in Q4 2025 and troughed at $482000.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets (Qtr)
1 Intuitive Surgical 148.09 Bn 143.69 Bn 1.83 Bn 20.11 Bn
2 Becton Dickinson 41.00 Bn 39.99 Bn 2.15 Bn 50.83 Bn
3 Medline 30.38 Bn 36.22 Bn 1.84 Bn 39.01 Bn
4 Resmed 28.22 Bn 26.56 Bn 890.98 Mn 8.78 Bn
5 West Pharmaceutical Services 23.72 Bn 23.19 Bn 296.40 Mn 4.11 Bn
6 Solventum 13.33 Bn 13.33 Bn 1.10 Bn 14.10 Bn
7 Cooper Companies 13.12 Bn 12.99 Bn 735.40 Mn 12.48 Bn
8 Align Technology 12.86 Bn 11.80 Bn 736.59 Mn 6.31 Bn
9 Baxter International 10.51 Bn 8.47 Bn 891.00 Mn 19.85 Bn
10 Regentis Biomaterials 3.72 Mn -3.66 Mn - 7.62 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 7.62 Mn
Dec 31, 2024 482,000.00